NVDA Volume Alert - NVDA 19.70 Nvidia Corp $NVDA Hit a high

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
NVDA Volume Alert - NVDA 19.70 Nvidia Corp $NVDA Hit a high of 20.01 Currently 11:15 Last price 19.70 -0.32 -1.60% With a day low of 19.70 and a current volume of 2,289,754.

NVDA Nvidia Corp Recent Headline News

Watch for Shares of Nvidia (NVDA) to Approach Support at $19.53
Comtex SmarTrend(R) - 2 hrs 29 mins ago
Nvidia (NASDAQ:NVDA) has opened bearishly below the pivot of $19.96 today and has reached the first level of support at $19.78. Should the shares continue to fall, the support pivots of $19.53 and $19.10 will be of interest.
NVDA: 19.65 (-0.37)

NVIDIA Corporation Earnings: The Future Is Getting Brighter
Adam Levine-Weinberg, The Motley Fool - Motley Fool - Mon Nov 10, 5:20PM CST
Graphics chipmaker NVIDIA  has sustained a string of strong earnings results , posting 50% earnings-per-share growth for the third quarter of its 2015 fiscal year. Its year-to-date earnings growth is also in the 50% range. Investors waited...
NVDA: 19.65 (-0.37)

Avoid The Hype: AMD's Decline Is Terminal
Alex Cho - at Seeking Alpha - Sat Nov 08, 9:00AM CST

AMD: 2.73 (-0.03), INTC: 33.29 (+0.03), NVDA: 19.65 (-0.37)

Water-Logged And Getting Wetter Stock Of The Day: NVIDIA (NVDA)
at The Street - Fri Nov 07, 9:33AM CST
Trade-Ideas LLC identified NVIDIA (NVDA) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
NVDA: 19.65 (-0.37)

NVIDIA Beats Q3 Earnings and Revenue Estimates; Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:40AM CST
NVIDIA Corp. (NVDA) reported third-quarter fiscal 2015 adjusted earnings of 33 cents per share, which comfortably surpassed the Zacks Consensus Estimate of 29 cents.
QCOM: 69.62 (+0.26), INTC: 33.29 (+0.03), DST: 98.46 (-0.99), NVDA: 19.65 (-0.37)

Nvidia higher as FQ3 beat dissected
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:31AM CST

NVDA: 19.65 (-0.37)

Stocks Set For Higher Start After Mixed Jobs Report
at Investor's Business Daily - Fri Nov 07, 8:01AM CST
The stock market today was poised for a higher open, despite a mixed jobs report issued Friday morning. Nasdaq 100 futures moved up 15 points vs. fair value, S&P 500 futures 3 points and Dow futures 26 points. In economic news, the economy added...
SWKS: 60.66 (-0.31), SLXP: 97.49 (+3.62), LOCO: 35.26 (-1.33), AAPL: 108.85 (+0.02), NVDA: 19.65 (-0.37)

NVIDIA Corporation (NVDA) CEO Jen-Hsun Huang on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 9:23PM CST

NVDA: 19.65 (-0.37)

NVIDIA Corporation Delivers Strong Results… Again
Ashraf Eassa, The Motley Fool - Motley Fool - Thu Nov 06, 8:22PM CST
NVIDIA , a company that specializes in graphics processing solutions for a wide variety of markets, reported strong earnings following market close on Nov. 6. The company delivered $1.225 billion in revenue, edging out analyst consensus of $1.2...
AAPL: 108.85 (+0.02), NVDA: 19.65 (-0.37)

Nvidia (NVDA) Q3 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 3:55PM CST

NVDA: 19.65 (-0.37)

Nvidia beats Street 3Q forecasts
Automated Insights - Thu Nov 06, 3:40PM CST
SANTA CLARA, Calif. (AP) _ Nvidia Corp. (NVDA) on Thursday reported profit of $173 million in its fiscal third quarter.
NVDA: 19.65 (-0.37)

Nvidia beats estimates, guides in-line
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 3:25PM CST

NVDA: 19.65 (-0.37)

NVIDIA Announces Financial Results for Third Quarter Fiscal 2015
Marketwired - Thu Nov 06, 3:20PM CST
NVIDIA (NASDAQ: NVDA)
NVDA: 19.65 (-0.37)

NVIDIA Corporation Earnings Preview: What You Need to Know
Ashraf Eassa, The Motley Fool - Motley Fool - Thu Nov 06, 2:50PM CST
NVIDIA , which develops graphics processing solutions for a number of end markets, has seen its stock price rise 25.66% year to date, crushing the Nasdaq 's  10.63% spike over that time . The stock price reflects a business that has performed well...
AMD: 2.73 (-0.03), NVDA: 19.65 (-0.37)

Stocks Cling To Modest Gains; Advance Auto Rebounds
at Investor's Business Daily - Thu Nov 06, 2:04PM CST
Stocks continued to hold slim gains Thursday afternoon. The Dow Jones industrial average led with a 0.3% gain, while the S&P 500 was up 0.2%. But the Nasdaq lagged with a 0.1% gain amid weakness in solar and chips. Volume was tracking lower across...
MNST: 106.84 (-0.92), ANET: 78.18 (+1.39), AAP: 144.36 (-0.81), SLXP: 97.49 (+3.62), DIS: 89.59 (-0.19), CDW: 32.58 (-0.17), NVDA: 19.65 (-0.37), FSLR: 51.02 (-0.94), LNKD: 228.75 (-0.50), LGF: 34.75 (-0.30), LOCO: 35.25 (-1.34), KING: 13.77 (+0.03)

AMD: A Misunderstood Opportunity With 50-100% Upside By 2017
Sacha May - at Seeking Alpha - Thu Nov 06, 1:11PM CST

AMD: 2.73 (-0.03), ARMH: 41.63 (-0.38), INTC: 33.29 (+0.03), NVDA: 19.65 (-0.37)

Stocks Down As Early Gains Fade; Generac Dives, Tableau Soars
at Investor's Business Daily - Thu Nov 06, 9:41AM CST
Stocks twisted opening gains into thin losses Thursday, as economic news and company reports fed the bulk of early action. The S&P 500 dipped 0.2%. The Nasdaq hovered a fraction into the red and the Dow Jones industrial average held effectively flat....
WFM: 47.09 (-0.96), TSLA: 248.53 (+6.60), AAP: 144.36 (-0.81), AKRX: 35.23 (-0.93), SLXP: 97.49 (+3.62), DIS: 89.59 (-0.19), GNW: 8.34 (+0.22), CDW: 32.58 (-0.17), NVDA: 19.65 (-0.37), QCOM: 69.62 (+0.26), GNRC: 42.33 (+1.64), LOCO: 35.25 (-1.34), DATA: 84.32 (+0.77)

Nvidia's Quarterly Performance To Be Driven By PC Gaming, Tegra Processors And Data Centers
Trefis - Seeking Alpha - Wed Nov 05, 5:52PM CST
Graphics processors manufacturer Nvidia (NASDAQ: NVDA ) will report its Q3 2015 earnings on November 6th. The company reported a 3.5% decline in its fiscal 2014 revenue as strength in its high-end products (including its GeForce GPUs and Quadro,...
NVDA: 19.65 (-0.37)

Will NVIDIA Corp. (NVDA) Surprise this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 3:10PM CST
NVIDIA Corp. (NVDA) is set to report the third-quarter fiscal 2015 results on Nov 6, 2014.
LMOS: 15.91 (+0.05), MANU: 15.87 (+0.09), HPQ: 36.72 (-0.18), NVDA: 19.65 (-0.37)

Watch for Nvidia to Potentially Pullback After Gaining 1.31% Yesterday
Comtex SmarTrend(R) - Tue Nov 04, 5:20PM CST
Nvidia (NASDAQ:NVDA) traded in a range yesterday that spanned from a low of $19.67 to a high of $20.20. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $20.06 on volume of 9.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NVDA: 19.65 (-0.37)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 321

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 237

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 443

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 22

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 254

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 253

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 238

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 86

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading

Top 5 Most Recently Viewed Articles

FCPT Expands Portfolio with $3.5 Million Veterinary Acquisition

Updated Category News Views 166

FCPT's Recent Acquisition Highlights Strategic Growth Four Corners Property Trust (NYSE:FCPT) has recently made headlines by acquiring a National Veterinary Associates property for $3.5 million. This acquisition signifies a notable addition to their expanding portfolio, reflecting FCPT's commitment to strategically investing in quality real estate. Details of the...

Continue Reading
Impact of National Security Probe on RH Stock Performance

Updated Category News Views 137

Unveiling the Impact of Recent National Security Investigations Shares of luxury furniture retailer RH have taken a significant hit due to President Donald Trump's announcement of a national security probe into furniture imports. This scrutiny has raised concerns across the home furnishings industry, known for its heavy reliance on global supply chains. Key Takeaways from...

Continue Reading
Understanding the Trends in Constellation Brands' Short Interest

Updated Category News Views 207

Exploring Constellation Brands' Short Interest Constellation Brands, identified by the ticker STZ, has recently reported an increase in its short percent of float, now at 10.22% since the last analysis. The company's latest data shows a total of 7.48 million shares sold short. This figure constitutes 4.42% of all available regular shares for trading. With an analysis...

Continue Reading
CTL's New Modular Monitor Aims to Redefine Flexibility

Updated Category News Views 7

CTL Unveils Innovative Modular Desktop Solutions CTL's latest move in the tech world features a new set of modular desktop products designed to cater to the education, enterprise, and government sectors. Their fresh offering—the CTL MTIP24OPS 24" Open Pluggable Specification (OPS)-Ready Monitor—comes along with two All-in-One computers operating on ChromeOS. This...

Continue Reading
Franklin Universal Trust Declares Monthly Share Distribution

Updated Category News Views 143

Franklin Universal Trust Announces Monthly Distribution Franklin Universal Trust [NYSE: FT] has declared a monthly distribution of $0.0425 per share, aimed at shareholders who are on record. This distribution is derived from net investment income and is set to be paid in the near future. Investment Objectives of the Fund The primary investment goal of Franklin Universal...

Continue Reading